Clinical Trial Update: Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating effects of GSK3640254 at therapeutic and supratherapeutic doses on cardiac conduction compared to placebo and moxifloxacin; results com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• GSK3640254
• Moxifloxacin (moxifloxacin)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2023-12-06